Evaluation of peripheral atherosclerosis: A comparative analysis of angiography and intravascular ultrasound imaging  by Arthurs, Zachary M. et al.
From the Peripheral Vascular Surgery Society
Evaluation of peripheral atherosclerosis:
A comparative analysis of angiography and
intravascular ultrasound imaging
Zachary M. Arthurs, MD, Paul D. Bishop, MSEE, Lindsay E. Feiten, BS, Matthew J. Eagleton, MD,
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Objective: Angiography remains a critical component for diagnostic imaging and therapeutic intervention in peripheral
arterial disease (PAD). The goal of this study was to compare angiography with corresponding intravascular ultrasound
(IVUS) imaging of the same vessels in patients with PAD.
Methods: From 2004 to 2008, 93 patients undergoing angiography for PAD were recruited in a prospective observational
analysis. At the time of angiography, diseased lower extremities were interrogated using a 10-cm IVUS pullback with
registration points. IVUS data were analyzed with radiofrequency techniques for vessel and lumen diameter, plaque
volume, plaque composition, and cross-sectional area. Similarly, three vascular surgeons blinded to the IVUS data graded
corresponding angiographic images according to vessel diameter, degree of stenosis, degree of calcification, and extent of
eccentricity. Statistical analyses of matched IVUS images and angiograms were performed.
Results: The distribution of demographic and risk variables were typical for PAD: 54% male, 96% hypertension, 78%
hyperlipidemia, 44% diabetic, 87% tobacco history, 65% coronary artery disease, and 10% end-stage renal disease.
Symptoms precipitating the angiographic evaluation included claudication (53%), rest pain (18%), and tissue loss (29%).
Angiographic and IVUS interpretation were similar for luminal diameters, but external vessel diameter was greater by
IVUS imaging (7.0  0.7 vs 5.2  0.8 mm, P < .05). The two-dimensional diameter method resulted in a significant
correlation for stenosis determination (r 0.84); however, IVUS determination of vessel area stenosis was greater by 10%
(95% confidence interval, 0.3%-21%, P < .05). IVUS imaging indicated that a higher proportion of plaques were
concentric. Grading of calcification was moderate to severe in 40% by angiography but in only 7% by IVUS (P < .05).
Conclusions: In the evaluation of PAD, angiography and IVUS imaging provide similar luminal diameters and diameter-
reducing stenosis measurements. Determination of overall vessel diameter and interpretation of plaque morphology by
angiography are discordant from IVUS-derived data. ( J Vasc Surg 2010;51:933-9.)Nearly 50 years after its invention, most vascular spe-
cialists still consider angiography to be the clinical gold
standard for defining peripheral arterial anatomy.1,2 An-
giography is often used to corroborate stenoses severity
documented by other imaging modalities, including ultra-
sound (US) imaging. However, angiography has many
limitations. Angiography depicts arterial anatomy in a two-
dimensional silhouette of the lumen that is dependent on
the angle of image projection. Confounding factors include
vessel tortuosity, obscure luminal shapes, concentric uni-
form lesions, and the evaluation of branch points. The
resolution of angiography is further limited by the radiation
exposure to the patient and arterial wall motion artifact.
Despite these limitations, angiography remains the stan-
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Advanced imaging modalities such as surface US imag-
ing, computed tomographic arteriography, and magnetic
resonance arteriography provide accurate arterial anatomy
but are unable to define the structural components of the
arterial wall. Intravascular US (IVUS) imaging, however,
can provide high yield structural detail with improved
resolution. We sought to compare standard digital subtrac-
tion angiography with IVUS imaging in patients being
evaluated and treated for peripheral arterial disease (PAD).
We compared angiography and IVUS imaging obtained
from the same lower extremity arteries.
METHODS
This study was approved by the Cleveland Clinic Foun-
dation’s Institutional Review Board (No. 6723), and par-
ticipants gave informed consent before enrollment.
Patient selection. This study design was a prospective
observational study. Patients with chronic lower extremity
ischemia undergoing lower extremity arteriography were
recruited for participation. Inclusion criteria were symp-
toms of intermittent claudication, rest pain, or minor tissue
loss (Rutherford category 1-5); ankle-brachial index (ABI)
0.9 in the affected lower extremity at rest or 0.80 after
exercise in patients with resting ABI 0.90; and angio-
graphic demonstration of a 100-mm patent segment of
933
JOURNAL OF VASCULAR SURGERY
April 2010934 Arthurs et alsuperficial femoral artery, common femoral artery, or exter-
nal iliac artery with at least one visually estimated stenosis of
30% diameter reduction. Patients were excluded if they
had acute limb ischemia, defined by a significant change in
symptoms; contraindications to angiography; concurrent
oral anticoagulant therapy that could not be safely with-
held; or extensive tissue loss or gangrene. Baseline demo-
graphics, medical comorbidities, clinical presentation, and
current medications were recorded.
Patients were offered enrollment from a single institu-
tion during the 4 years between 2004 and 2008, and data
were collected in a prospective manner. A total of 93 were
enrolled from a group of about 800 patients per year
undergoing angiography with or without an intervention.
This low number reflected the strictness of inclusion criteria
mostly due to the requirement of a 100-mm patent vessel
for imaging in the setting of PAD needing angiography and
possible intervention.
Data acquisition. Angiography was performed with a
fixed digital Angiostar angiographic system (Siemens AG,
Munich, Germany), and original angiographic images were
stored electronically (Magicview, Siemens AG). At the time
of IVUS imaging, reference points were marked on angio-
graphic images to directly compare the same 10-cm seg-
ment of artery. Three surgeons blinded to the IVUS results
evaluated angiographic runs matched to the IVUS pull-
back. Angiographic images were selected for review that
clearly delineated the diseased segments. Multiple planar
images were not routinely obtained.
Evaluation of the angiograms included determination of
proximal and distal diameters, diameter-reducing percentage
of stenosis, stenosis concentricity (graded as concentric or
eccentric), and grading of stenosis calcification. Stenosis per-
centage was determined by using the proximal adjacent
healthy artery as the reference (1 – stenosis diameter/proximal
diameter). Grading of calcium was scored on the following
scale: none, minimal, moderate, and severe calcification.3 Di-
ameters and length of stenoses were reported in millimeters.
Extent of atherosclerosis was categorized as involving33%,
33% to 67%, and67% of the analyzed segment.
During angiography, IVUS pullback was performed
over a 10-cm segment with at least one 30% stenosis. All
IVUS data were obtained using the In-Vision Gold IVUS
console (Volcano Corp, Rancho Cordova, Calif), and the
3.5F Eagle Eye phased array IVUS catheter. The catheter
tracks over a 0.014-inch guide wire system and has a
20-MHz US probe that produces a 20-mm field of view.
During IVUS imaging, the catheter was advanced to the
most distal aspect of the lesion, and then data were col-
lected at a 1 frame/s using a Trak Back II, pullback device
set at a motorized pullback rate of 0.5 mm/s.
Raw sequential radiofrequency (RF) IVUS data were
saved and transferred to a workstation for analysis. Gray-
scale images were also acquired and assisted in the vessel
contour definition process. Fiduciary points to aid in direct
comparison of IVUS and angiographic images included
branch points and matching of start/stop single fluoro-
scopic images. Of the 93 enrolled patients, 61 had directlycomparable angiographic and IVUS images for analysis.
Reasons for excluding IVUS imaging included the medial-
adventitial border beyond the IVUS imaging field, poor
resolution, lack of a complete 100-mm pullback, and other
technical issues (n  32).
IVUS images were reconstructed from RF data using
IVUS lab software.4 Contours defining the internal elastic
lamina and external elastic lamina of the vessel were iden-
tified automatically by the postprocessing software. Lumen
and media-adventitial contours were then manually cor-
rected for each gray scale image by a technician and rever-
ified by another. IVUS analyses produced two distinct
measurements for stenoses:
1. Diameter stenosis 1 lumen diameter/vessel diameter.
2. Area stenosis  1  lumen area/vessel area.
Atherosclerotic plaque compositionwas then computed using
Volcano’s Virtual Histology (VH) atherosclerotic plaque
characterization algorithm. This tissue characterization is val-
idated to a 10-mm field of view. Atherosclerotic plaques were
characterized as fibrous, necrotic, or dense calcium. The out-
put from the VH IVUS software yielded cross-sectional area
information expressed in mm2.
Statistical analyses. Patient variables are expressed as
proportions for dichotomous variables and mean  stan-
dard deviation for continuous variables. Differences be-
tween angiography and IVUS images were determined by
the paired t test for parametric data. The 2 test was used for
comparisons of nominal data, and the Fischer exact test was
used when appropriate. To assess inter-rater concordance and
agreement between angiography and IVUS, linear regression
with Pearson product correlation coefficients were reported
for parametric variables, and 2 test with Spearman rank
correlation coefficients were reported for nonparametric data.
Statistical significance was set at P  .05. All analysis was
performed using SPSS 16.0 software (SPSS Inc, Chicago, Ill).
RESULTS
During the study period, 93 patients (54% men) were
enrolled in the prospective study, and their characteristics
are listed in Table I. Their mean age was 68 10 years. The
Table I. Characteristics of the patients in the cohort
Variable Mean  SD, or percentage (n  93)
Age, y 68  10
Male 54
Hypertension 96
Hyperlipidemia 78
Diabetes 44
Smoking history 87
Creatinine, mg/dL 1.22  0.8
End-stage renal disease 10
Presenting symptoms
Claudication 53
Rest pain 18
Tissue loss 29risk factors for atherosclerosis were prevalent in this popu-
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maining patients presented with rest pain or tissue loss. The
distribution of arteries analyzed included the common iliac
artery, 7%; external iliac artery, 7%; superficial femoral
artery, 73%; and the popliteal artery, 14%. The cohort
primarily consisted of lesions in the superficial femoral
artery, and 86% of those stenoses were located in the distal
one-third of the superficial femoral artery.
Inter-rater concordance among angiographic examin-
ers was evaluated using linear regression and calculation of
Pearson correlation coefficients. The evaluation of 61 im-
ages for discrete angiographic measurements showed high
inter-rater agreement for percentage of luminal stenosis
(r 0.89, Fig 1), proximal diameter (r 0.92), and distal
diameter (r  0.87). However, the qualitative assessment
of angiographic concentricity (r  0.26), plaque calcifica-
tion (r 0.64), length of stenosis (r 0.66), and extent of
atherosclerosis (r  0.66) yielded very poor inter-rater
agreement among angiographic examiners.
To compare discrete measurements, a paired analysis
was performed between angiographic and IVUS measures
for diameters and maximal luminal stenosis (Table II). For
both proximal and distal diameters, there was no significant
difference in the assessment of actual lumen diameter in the
vessel. Agreement between angiographic and IVUS lumi-
nal measurements was as high as 95%. Although only one
vessel diameter can usually be assessed with conventional
arteriography, IVUS determined both a luminal and outer
wall diameter. Overall vessel size was approximately 1 to 2
mm larger than the luminal measurement at both locations.
Likewise, luminal assessment of maximal stenosis was com-
parable for both angiography and IVUS, with good overall
agreement. With IVUS, the maximal percentage area of
stenosis was measured, and when compared with angiogra-
phy, IVUS-derived degree of stenosis was greater by 10%
(95% confidence interval [CI], 0.3%-21%; P  .05).
Plaque characteristics where compared in a similar fash-
Fig 1. Inter-rater concordance is shown among angiographic
examiners for determining maximal percent stenosis. The open
circles represent actual measured data points among examiners, the
solid black represents the linear regression through those points,
and the hashed red line represents the 95% confidence interval.ion. Table III lists a paired assessment of length of stenosis,evaluation of concentricity, and estimation of calcification.
By angiography, the length of stenosis was 14.3 12 mm,
but the same stenosis was 17.3 13mmby IVUS imaging,
a 3.0-mm difference (95% CI, 0.9-5.1 mm; P  .05).
When determining the extent of calcification in a
plaque, angiographic examiners found higher calcium bur-
den within a lesion. Angiographic interpretation classified
40% of plaques as moderate or severe calcification, whereas
IVUS evaluation only yielded 7% of patients meeting the
criteria for moderate calcification and 0% for severe calcifi-
cation (P .05). In addition, angiographic examiners rated
72% of lesions as eccentric and the remaining 28% as
concentric. In evaluating concentricity by IVUS technique,
a plaque diameter index was used where0.33 indicated a
concentric lesion. By IVUS measurements, only 40% of
lesions were eccentric and the remainder concentric.
Additional data obtainable only by IVUS imaging in-
cluded plaque morphology and volume. Evaluation of the
arterial segments with IVUS VH software determined that
63% of stenoses in this sample were primarily composed of
fibrous plaque, 14%were classified as necrotic plaques, 9% had
calcific plaques, and 14% were of mixed composition. Overall
plaque burden for the area of pullback was 150  44 mm3/
cm. This indicated the volume of plaque in the diseased
arteries. The average cross-sectional areas for the vessel, lu-
men, and plaquewere 30.78.9mm2, 15.56.4mm2, and
15.1 4.7mm3, respectively. Fig 2 illustrates a an example of
angiographic and IVUS analysis in a single vessel.
DISCUSSION
Contrast angiography is paramount for the evaluation
and management of PAD, but it has significant limitations
for evaluating atherosclerotic disease. The disassociation of
angiographic findings and histologic analysis has been doc-
umented in both the coronary and peripheral vascular
territories. Autopsy studies in patients who had undergone
coronary angiography determined that 33% had coronary
atherosclerosis that was unidentified by angiography.5 In
the peripheral vascular bed, we studied a select group of
patients who had undergone angiography before amputation.
The angiograms were compared with perfusion fixed arterial
histology obtained from amputation specimens.6 Angiogra-
phy underestimated stenoses severity, arterial diameter, and
was discordant from actual plaque architecture.6,7
Limitations of angiographic evaluationmay account for
the discordant results of treatment for PAD. In the treat-
ment of femoral-popliteal disease, trials comparing medical
therapy vs angioplasty for the treatment of claudication
have failed to demonstrate a difference in symptom relief or
walking distance during 2 to 6 years of follow-up.8-10 This
may reflect both recurrent disease and remnant occlusive
disease that was not completely treated initially.
The Bypass Versus Angioplasty in Severe Ischemia of
the Leg (BASIL) trial compared surgical bypass with per-
cutaneous transluminal angioplasty in the treatment of
chronic limb ischemia due to infrainguinal disease. No
demonstrable differences were identified in amputation-
free survival.11 However, technical failures occurred in 20%
is (or
S mea
S mea
JOURNAL OF VASCULAR SURGERY
April 2010936 Arthurs et alof patients in the angioplasty arm and a high fraction of
angioplasty patients required secondary procedures.
Lastly, the addition of self-expanding stents and stent
grafts has improved the immediate angiographic result but
has failed to demonstrate an improvement in long-term
ambulatory status and amputation-free survival.12-14
We speculate that advances in intraprocedural imaging
may aid in the performance and durability of endovascular
therapies. Much of our understanding of peripheral athero-
sclerosis comes from studies in coronary arteries. IVUS
imaging is a highly sensitive imagingmodality that has been
used to show a reduced rate of progression of atheroma
burden in coronary vessels that could not be done using
conventional angiography alone.15
In the present study, angiography was compared with
IVUS imaging in the same arteries in patients presenting
with PAD. Angiography and IVUS imaging provided con-
cordant data on luminal diameters and maximal diameter
stenoses. IVUS imaging provided additional information
to include outer vessel diameter and maximal area stenosis.
Given the irregular contour of the luminal surface, not all
area stenoses were much greater than the diameter stenosis
by IVUS imaging. For instance, a concentric narrowing will
give an area stenosis larger than the diameter stenosis. On
the other hand, a web-like stenosis may give a diameter
stenosis larger than the area stenosis. Both measurement
techniques give important information about the stenosis.
The length of stenosis, plaque concentricity, and degree of
plaque calcification determined by IVUS imaging were
discordant to angiographic derived interpretation.
Angiographic luminal assessment is reliable but subject
Table II. A paired analysis of angiographic and intravascu
vessel segments
Variable Angiographic analysis
Proximal diameter, mm 5.5  0.7
Distal diameter, mm 5.2  0.8
Stenosis, % 46  27
aSignificance level of the paired t test for continuous variables and 2 analys
bCorrelation coefficient for the relationship between angiographic and IVU
Table III. A paired analysis of angiographic and intravasc
corresponding arterial vessel segments
Variable Angiographic analysis
Length of stenosis, mm 14.3  12
Calcification
None 26%
Mild 33%
Moderate 28%
Severe 12%
aSignificance level of the paired t test for continuous variables and 2 analys
bCorrelation coefficient for the relationship between angiographic and IVUto error. The silhouette of a complex irregular lumen withcalcium and thrombus superimposed poorly represents the
actual lumen. Vessel movement and tortuosity further
compound the luminal interpretation. In addition, angio-
grams cannot truly assess a disease-free reference segment
for adequate comparison; a diffusely diseased artery may be
interpreted as having no abnormalities. When the maximal
diameter stenosis from angiography was compared with the
maximal area stenosis from IVUS imaging, IVUS-derived
data were greater by 10%. Also, when the overall length of
plaque stenosis was determined, angiography-derived
length of stenoses were 3-mm shorter than IVUS data. This
difference in interpretation may account for some of the
false-negative studies (33% to 39%) identified in postmor-
tem histologic studies compared with angiography.5,6
Quantitative gray-scale IVUS images are limited by
geometric measurements obtained by the end user or a
software program, but limited objective information can be
obtained from the echogenic interpretation of plaque char-
acteristics. Qualitative assessment of echogenicity alone can
be inaccurate due to the similarities of echogenicity be-
tween different tissue compositions: thrombus, lipids, fi-
brous, and calcific. Analyzing the raw RF data obtained
from IVUS imaging allows the development of RF spectral
profiles for different tissue types. This novel process, virtual
histology, allows the objective classification of plaque mor-
phology into the three primary categories of fibrous, cal-
cific, and necrotic. This technology has most commonly
been applied to the coronary vascular bed,16,17 and the
algorithm has been validated for carotid arteries.18
Qualitative variables assessed by angiography were differ-
ent than IVUS-derived measurements. Plaque concentricity
ltrasound (IVUS) measurements in corresponding arterial
IVUS analysis Pa rb
n diameter 5.3  0.9 .45 0.95
r wall diameter 7.0  0.7 .05 0.28
n diameter 5.2  0.9 .642 0.94
r wall diameter 7.0  0.7 .05 0.31
eter method 49  25 .61 0.84
method 55  22 .05 0.46
Fischer exact test where appropriate) for proportions.
surements.
ltrasound (IVUS) assessments of plaque characteristics in
IVUS analysis Pa rb
17.3  13 .05 0.80
.05 0.27
alcium 0%-5% 51%
5%-15% 42%
15%-25% 7%
25% 0%
Fischer exact test where appropriate) for proportions.
surements.lar u
Lume
Oute
Lume
Oute
Diam
Areaular u
C
is (orwasmuchgreater by IVUS imaging than by angiography. The
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comparable with angiography or any other surface imaging
modality. Plaque morphology, including calcification, can be
characterized by objective parameters with IVUS imaging
and was less severe than estimated by angiography. Most
lesions in this area were classified as fibrous by their RF
profile. In a previous study, Bishop et al7 identified increas-
ing calcification with increasing distance from the popliteal
artery irrespective of known clinical risk factors (diabetes,
hyperlipidemia, and chronic kidney disease). In the present
study, the superficial femoral artery comprised the majority
of the population, and 44% of patients were diabetic, 78%
were hyperlipidemic, and 10% had end-stage renal disease.
The proximal vessels interrogated explain the relatively low
percentage of calcific plaques observed in this study.
Despite the provocative results presented here, the
clinical benefits of using IVUS imaging routinely and of
plaque characterization in the periphery are largely un-
known. This study highlights perhaps some of the limita-
tions of angiography and illustrates the additional informa-
Fig 2. An example of angiographic and intravascular ul
in the angiogram marks the area for analysis. This was in
grey scale imaging through this area is illustrated. The yell
the external elastic lamina. By IVUS, this represents a 76%
the dark and light green shades denote fibrous plaque,
represent necrotic plaque, and white areas denote calciution obtained from IVUS interrogation. We are currentlyevaluating the clinical response to endovascular therapy in a
larger cohort of PAD patients. It is foreseeable that partic-
ular plaque compositions may respond more favorably to
endovascular intervention whereas certain subgroups should
be reserved for surgical bypass. However, cost, additional
operative/fluoroscopic time secondary to catheter exchanges,
and additional equipment and personnel are additional hur-
dles that must be overcome for IVUS imaging to be used
routinely.
Endovascular therapies are now routinely used as a
revascularization modality in the lower extremities but
suffer from limited durability.11,14 Because most endovas-
cular therapies are performed using angiography alone,
unrecognized disease may cause decreased patency. Our
study illustrates the difficulties of determining the begin-
ning and end of disease with angiography, which may lead
to inadequate treatment of the occlusive process. Further-
more, sizing of endovascular devices, including balloons for
angioplasty and stents, are made by luminal rather than true
vessel diameters. Thus, patients may return for treatment of
nd (IVUS) analysis is shown. A, The large white arrow
ted as a 30% stenosis based on the angiogram. B, IVUS
emarks the internal elastic lamina, and the red linemarks
stenosis.C, In this example of virtual histology analysis,
accounts for the majority of this lesion, the red areastrasou
terpre
ow lin
area
whichremnant rather than recurrent disease.
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outcomes in patients undergoing iliac PTA and stenting.
They concluded that IVUS imaging helped define arterial
diameter and adequacy of stent deployment and led to im-
proved patency and negating secondary procedures.19
Whether routine IVUS usage during endovascular therapy
would lead to improvements in treatment of infrainguinal
disease remains unknown. More work in this arena is needed.
This study has some limitations that deserve mention.
The small sample size subjects the study to potential un-
measured covariates and type II error. But given that this
study was a paired analysis, we believe that a larger sample
size would not affect our conclusions. The selected cohort
somewhat limits the generalizability of the results. Despite
a large clinical volume, we had difficulty enrolling patients
into this trial. This is somewhat reflective of the strict
inclusion and exclusion criteria, including the need for
angiography and intervention, but with a patent 100-mm
segment of lower extremity artery. In addition, the distal
superficial femoral artery and popliteal artery comprised
most of the data set; therefore, the results may not apply to
the iliac or tibial vessels.
Angiography has been criticized for having poor
interobserver reliability,20 but in our study, inter-rater
agreement was as high as 95% for discrete measurements
between three surgeons. Because the complete media-
adventitial border was not completely visualized by IVUS
imaging, nearly one third of patients were excluded from
analysis. This was largely experienced at the beginning of
the study enrollment and in the larger arteries examined.
To decrease interobserver variability, software compa-
nies have designed programs, quantitative vessel analysis
(QVA) software, that are intended to eliminate the exam-
iner error with an objective, computer-basedmeasurement.
Unfortunately, these programs have the same limitations of
conventional interpretation. QVA uses the lumenogram to
obtain discrete diameters and calculate percentage stenosis.
Inter-rater agreement was very poor for qualitative mea-
surements of vessel concentricity, extent of calcification, and
extent of atherosclerosis, andQVAwould not be able to assess
those variables. Given the high inter-rater agreement between
angiographic examiners and the assumption that most vascu-
lar surgeons assess their own imaging, we do not believe that
the addition of QVA would affect our results.
CONCLUSIONS
The evaluation and treatment of PAD depends on
accurate angiographic imaging. Luminal quantitative as-
sessments are very reliable with angiography, but assess-
ment of true vessel diameter, actual area stenosis, plaque
concentricity, and calcification are extremely discordant
with IVUS imaging. In addition, IVUS imaging offers an
objective assessment of plaque morphology. A better un-
derstanding of vessel and plaque morphology may identify
parameters other than luminal flow-limiting stenoses in
which to guide our therapeutic approach to PAD.REFERENCES
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Dr Peter Nelson (Gainesville, Fla). Dr Arthurs and his coau-
thors have scientifically brought to our attention the limitations of
conventional angiography or what can be referred to as a 2D “lume-
nagram.” From their data, intravascular ultrasound (IVUS) provides
significant additional detail with respect to arterial morphology, spe-
cifically the measurement of true vessel outer wall diameter, area
stenosis, and lesion length, all of which are underestimated by angiog-
raphy, and importantly, information regarding plaque morphology
and virtual histology that is simply unavailable from angiography
alone. I offer the following technical and practical questions:
First, in your study angiography was accurate at predicting
luminal diameters and importantly, maximal diameter stenosis.
Isn’t this enough information to make intraprocedural decisions
regarding intervention, or do we need more information? For
example, is the additional information that IVUS provides regard-
ing full vessel diameter really necessary since it is standard practice
to oversize stents and devices based on conventional angiography?
Or, does the area of stenosis really add anything? The case example
that you showed in your presentation I think is certainly telling, but
if there is a false-negative on angiography, do you think that that
lesion would turn out to be hemodynamically significant?
Second, with the increased capability and utility of noninvasive
imaging such as CT [computed tomography] or MR [magnetic
resonance] angiography (CTA or MRA), is some or all of this infor-
mation potentially obtainable before performing angiography and
therefore be potentially useful information for case-based planning?
Third, you point out that you had relatively few heavily
calcified arteries in your study. Was this the result of case selection
and/or do you have experience with calcified vessels and how does
IVUS perform in that setting? Does shadowing or signal drop-out
limit its utility in such cases?
Next, you have excluded chronic total occlusions in order to
maintain the focus of the study, but do you have information as to
whether there is any utility for IVUS in chronic occlusions and, if
so, what information it provides?
And finally, can IVUS provide any hemodynamic information,
either pressure readings or, more importantly, Doppler velocities or
color flow measurements which would really provide added utility in
determining the hemodynamic significance of stenotic lesions and
then, in turn, ultimately guide the adequacy of your intervention.
Dr Zachary M. Arthurs. In regard to the first question,
angiography provides a good luminal assessment. Does knowing
the true vessel diameter and area of stenosis really matter? In order
to understand the extent of atherosclerotic burden, I think the true
vessel and area stenosis are important. In the example illustrated,
the superficial femoral artery appears to be a reasonably healthy
vessel by angiography, but it is truly diseased throughout the entire
length. This accounts for significant underestimation of disease.
Are these lesions hemodynamically significant? Pressure mea-
surements over long lesions are difficult to interpret. At this time,
I would rely on noninvasive physiologic testing in order to deter-
mine their clinical impact. Based on the observation nature of the
current study, I can determine the overall clinical impact of IVUS.
In the current state, surface imaging cannot obtain the reso-
lution needed to assess the vessel wall in the periphery. Magnetic
resonance imaging has been evaluated extensively in the carotid
bed, and computed tomography in the coronary bed. In the
periphery, it is very good for case planning, but I don’t think it
adequately assesses extent of disease.
In regard to the extent of calcification identified in our study,
I think this is appropriate for the population studied. We have
observed increasing calcification as you proceed down the periph-
eral tree, specifically in the tibioperoneal trunk and in the tibial
vessels. Since our cohort was primarily superficial femoral artery
lesions, I think this is an accurate finding. In addition, the angio-
graphic evaluators, although experienced, overestimated calcifica-
tion compared to IVUS.Utilizing IVUS for chronic total occlusions poses several
challenges. Placing the catheter in a subintimal plane vs through a
central core will add variability to the interpretation. If predilation
is needed in order to pass the 3.5F catheter, the images will be
obscured as well. For these reasons, we have not utilized IVUS
consistently for chronic total occlusions.
In my experience, I have not used IVUS to assess hemody-
namic information. At the current time, flow velocities and pres-
sure measurement are not able to be measured.
Dr Hasan Dosluoglu (Buffalo, NY). All the operators in this
groupwere experienced, and although I thought that there was a 10%
mismatch overall, the example you showed us was 74%. So what was
the variation of the scores between the angiographic assessment and
the IVUS assessment? What was the plus and minus standard devia-
tion of that 10%?Which particular lesions were these very experienced
operators particularly wrong? In other words, which type of vessels or
lesions would IVUS be most beneficial to the interventionist?
Dr Arthurs. The example I gave you, of course, was an extreme
example, 20% to 30%, to an area of stenosis of 76%. Even if you did a
luminal calculation on that vessel I showed you, you would still
probably get a 30% or 40% stenosis because it is diffusely diseased
along the entire vessel and you are not using the true vessel diameter
as your denominator to calculate the stenosis. On average, luminal
diameter assessment underestimates the area of stenosis by 10%.
Angiographic evaluates were most discordant when it came to
the qualitative assessment of the plaque. There was actually very good
agreement on the luminal calculations of diameter and stenosis.
Dr Anil Hingorani (Brooklyn, NY). How much did it cost?
Dr Arthurs. Looking at the IVUS catheter itself, depending
on your pricing that you are able to obtain, each individual catheter
could be as low as $700 to as high as $1200, I’ve been told by some
vascular surgeons that use them. On top of that, you have to buy or
lease the actual hard drive, monitors, and software.
DrHingorani.Has this resulted in a change in your practice?
Dr Arthurs. Today, no. It makes me more conscious when
interpreting peripheral angiograms and basing either endoluminal
or surgical therapy.
Dr Hingorani. And finally, can you just go into a little more
detail how 93 patients were selected out of 3200 patients, roughly?
Dr Arthurs. That illustrates the enrollment difficulties. The
main enrollment barrier was identifying patients that had a patent
vessel with an indication to undergo angiogram; and in addition,
patient hesitation to consent for something that they otherwise
would not have obtained if they weren’t part of the study.
Dr Panagiotis Kougias (Houston, Tex). Most people would
agree that one of the best applications of IVUS would be to assess
the adequacy of an endovascular intervention in the SFA.Have you
used this at all for this purpose?
Dr Arthurs. I have used it for that application, but only have
anecdotal experience.
Dr Vikram Kashyap. I just wanted to put this study in
context. This is part of an NIH [National Institutes of Health]-
sponsored study. In this particular report we looked at the disparity
between IVUS results and angiography in lower extremity lesions.
We all know that there is a finite durability of our endovascular
therapies. It may vary from institution, from the area of the
vasculature treated, or from the modality that’s used, but we all
know that the durability is limited.
I think one takeaway message is often we don’t treat resteno-
sis, but what we treat is remnant disease that we didn’t recognize
initially.
The second point is that the virtual histology is a very compel-
ling area. We hope to eventually get parameters that are predictive
of success or failure. That is, highly calcific vessels may be better
treated with one modality, such as atherectomy or cryoplasty, and
perhaps fibrous lesions are better treated with another modality
like stenting. We are not there yet, but that is the goal.
